Individualised adjuvant immunotherapy with neoantigen‐reactive T cells for gastric signet‐ring cell carcinoma

OBJECTIVES: The signet‐ring cell carcinoma (SRCC) of the stomach is highly invasive. Patients with stage III gastric SRCC usually experience tumor recurrence within 2 years after radical surgery. Unfortunately, there is no effective treatment to postpone recurrence following adjuvant chemotherapy. O...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Naiqing, Liu, Qin, Du, Juan, Shao, Jie, Yang, Yang, Yang, Ju, Chen, Fangjun, Yu, Lixia, Liu, Baorui, Wei, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494288/
https://www.ncbi.nlm.nih.gov/pubmed/37700856
http://dx.doi.org/10.1002/cti2.1467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494288/
https://www.ncbi.nlm.nih.gov/pubmed/37700856
http://dx.doi.org/10.1002/cti2.1467

Ejemplares similares